Skip to main content
. 2017 Jul 10;8(40):68038–68046. doi: 10.18632/oncotarget.19145

Table 1. Clinical characteristics of each patient and intraprostatic lesion (IPL).

Patient Gleason score Clinical stage PSA prior to biopsy Previous biopsies
1 3 + 3 = 6 T1c 4.1 0
2 3 + 3 = 6 T2a 2.95 1
3a 3 + 3 = 6 T1c 5.17 1
3b 3 + 3 = 6 T1c 5.17 1
4 3 + 3 = 6 T1c 6 1
5 3 + 3 = 6 T1c 4.5 0
6 3 + 3 = 6 T1c 5 4
7 4 + 4 = 8 T1c 9 2
8 4 + 4 = 8 T1c 5.1 1
9 4 + 5 = 9 T1c 15.2 4
10 4 + 5 = 9 T1c 9.02 2
11 5 + 5 = 10 T1c 6.19 0